Tag: ESKD
Outset Medical and US Renal Care announce collaboration aimed to grow...
Outset Medical and US Renal Care have announced via press release a multi-year agreement to help accelerate home haemodialysis in the USA.
According to their announcement, studies...
Significant milestones of the Alio SmartPatch™ to enable remote monitoring of...
This advertorial is sponsored by Alio
With one in three people living with diabetes and one in five with hypertension, the risk of chronic kidney...
World’s first successful genetically-edited pig kidney transplant performed in US
A recent attempted transplant of a genetically-edited pig kidney has been successfully carried out for the first time at Massachusetts General Hospital (MGH) in...
CKD patient outcomes affected by low screening rates in deprived areas,...
Vizient has announced the publication of its first public report on care utilisation and quality in the USA using data from Medicare's Data Sharing for...
ESKD Summit 2023: What matters to patients gains momentum with input...
This advertorial is sponsored by BD.
Focusing on the disease through the patient’s lens, establishing well-functioning multidisciplinary teams, to potentially enhance both the patient’s journey...
Renal Interventions 9 – US
Highlights
Patient perspectives highlighted in conversation with representatives Vivian Papageorgiou and Phil West.
Endo Vascular Access Meeting 2023 (EVA; 23–24 June, Patras, Greece) coverage...
Renal Interventions 9 – EU
Highlights
Patient perspectives highlighted in conversation with representatives Vivian Papageorgiou and Phil West.
Endo Vascular Access Meeting 2023 (EVA; 23–24 June, Patras, Greece) coverage...
Haemodiafiltration mortality risk found lower than haemodialysis
The publication in The New England Journal of Medicine (NEJM) of new research on haemodiafiltration comes following a series of inconclusive prior studies. Lead...
Personalised exercise for dialysis patients cuts hospital admission
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not....
First enrolment in trial of secondary hyperparathyroidism drug for ESKD patients
Pathalys Pharma and Launch Therapeutics have announced that the first patient has been enrolled in the PATH (PTH Attenuation Trial in Hemodialysis) clinical programme,...
Improving access to kidney care for underrepresented ESKD patients
Michael Casey is a transplant nephrologist and Derek DuBay is a transplant surgeon at the Medical University of South Carolina (Charleston, USA). They write...
Alio receives second FDA clearance
Alio, the medical technology company behind the SmartPatch device for chronic disease, has announced its latest US Food and Drug Administration (FDA) clearance. The...
Experts react to “compelling” 36-month IN.PACT AV Access trial data
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Shahverdyan (Hamburg, Germany), Matteo Tozzi (Varese, Italy), Alexandros Mallios (Paris,...
Multidisciplinary community unites at inaugural patient-focused ESKD Summit
This advertorial, sponsored by BD, is only available in selected countries and geographies.
“The Changing Face of a Dialysis Patient” was the central theme...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
UK Renal Registry: Peritoneal dialysis climbs despite overall RRT decrease
With comprehensive UK Renal Registry (UKRR) data from 2020 set to be published by the UK Kidney Association (UKKA) imminently, Renal Interventions previews a...
The Alio SmartPatch™: Optimising dialysis patient monitoring with a wearable, non-invasive...
This advertorial is sponsored by Alio Medical
Owing to the various risk factors and potential complications faced by kidney disease patients undergoing dialysis treatment, new...
Fresenius launches My Reason campaign to enrol patients in kidney-focused genomics...
Fresenius Medical Care announced today that its Global Medical Office has launched the My Reason campaign to promote patient enrolment in the company's kidney-focused genomics registry, which was...
Charmaine Lok
Equally at home on the ward seeing patients, at study sites conducting research, and travelling the world for voluntary medical missions, Charmaine Lok has...
Systematic review sheds light on “unpleasant necessity” of cannulation for haemodialysis...
A systematic review published in the Journal of Vascular Access (JVA) has illuminated haemodialysis patients’ views and experiences of arteriovenous access cannulation, concluding that...
IMPRESSION trial assessing MagicTouch AVF passes 50% enrolment
Concept Medical has shared the latest update from its IMPRESSION (Sirolimus-coated balloon angioplasty versus plain balloon angioplasty in the treatment of dialysis access dysfunction)...